Construction of a self-amplifying mRNA-LNP complex for phenylalanine hydroxylase and its efficacy evaluation in gene therapy for phenylketonuria
Ziqi Wen, Yiling Long, Wenjing Shi, Wenjing Song, Rongjun Xu, Xingri Zhan, Xiuyuan Wang, Rui Su, Yu Wang, Jia Fei · 2026
Read Construction of a self-amplifying mRNA-LNP complex for phenylalanine hydroxylase and its efficacy evaluation in gene therapy for phenylketonuria by Ziqi Wen, Yiling Long, Wenjing Shi, Wenjing Song, Rongjun Xu, Xingri Zhan, Xiuyuan Wang, Rui Su, Yu Wang, Jia Fei (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13594751.txt.
Description
Ziqi Wen and co-authors build a gene therapy for phenylketonuria in a 2026 study. The inherited disorder leaves the body short of an enzyme that breaks down phenylalanine, an amino acid that then builds up to harmful levels. Current drugs help only some patients and carry age limits.
The team packed mRNA for the missing enzyme into fat particles aimed at the liver. One version copies itself inside cells, so a small dose lasts longer. In mice bred to lack the enzyme, the self-copying version matched the plain version at one-sixth the dose. It held amino acid levels in the healthy range for 14 days, while plain mRNA faded fast. Repeat doses caused no clear immune reaction or liver harm.
Catalog record
| CREATOR | Ziqi Wen, Yiling Long, Wenjing Shi, Wenjing Song, Rongjun Xu, Xingri Zhan, Xiuyuan Wang, Rui Su, Yu Wang, Jia Fei |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 49 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |